IPHA Competitors & Alternatives
Compare Innate Pharma with similar stocks in the same industry
Biotechnology
IPHA
Main Stock$1.75
Tradestie Score
51
Market Cap
$182.31M
Revenue Growth
-0.5%
Analyst Upside
+242.9%
Top Competitors
233 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
SLS
SELLAS Life Sciences Group, Inc. Common Stock
|
$13.19
|
$211.22M | - | 54 | Compare |
|
ACRS
Aclaris Therapeutics, Inc.
|
$5.68
|
$202.58M | - | 60 | Compare |
|
ASMB
Assembly Biosciences, Inc
|
$26.81
|
$188.81M | 336.8 | 54 | Compare |
|
FBRX
Forte Biosciences, Inc. Common Stock
|
$48.86
|
$180.53M | - | 56 | Compare |
|
AVTX
Avalo Therapeutics, Inc. Common Stock
|
$19.37
|
$170.45M | - | 58 | Compare |
|
ACHV
Achieve Life Sciences, Inc.
|
$6.27
|
$158.43M | - | 58 | Compare |
|
NVCT
Nuvectis Pharma, Inc. Common Stock
|
$19.14
|
$154.27M | - | 51 | Compare |
|
CLYM
Climb Bio, Inc. Common Stock
|
$12.70
|
$133.50M | - | 58 | Compare |
|
STTK
Shattuck Labs, Inc. Common Stock
|
$7.53
|
$114.01M | - | 61 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$27.54
|
$110.20M | - | 65 | Compare |
More IPHA Analysis
Data updated: Jul 17, 2026 | Industry: Biotechnology (SIC 2836)
233 stocks in this industry